26. Referanser

Abdel Khalek Abdel Razek, A., & King, A. (2012). MRI and CT of nasopharyngeal carcinoma. AJR: American Journal of Roentgenology, 198(1), 11-18. https://doi.org/10.2214/ajr.11.6954

Agarwal, J. P., Nemade, B., Murthy, V., Ghosh-Laskar, S., Budrukkar, A., Gupta, T., . . . Dinshaw, K. (2008). Hypofractionated, palliative radiotherapy for advanced head and neck cancer. Radiotherapy and Oncology, 89(1), 51-56. https://doi.org/10.1016/j.radonc.2008.06.007

Ahn, P. H., Mitra, N., Alonso-Basanta, M., Palmer, J. N., Adappa, N. D., O'Malley, B. W., Jr., . . . Lin, A. (2016). Risk of lymph node metastasis and recommendations for elective nodal treatment in squamous cell carcinoma of the nasal cavity and maxillary sinus: a SEER analysis. Acta Oncologica, 55(9-10), 1107-1114. https://doi.org/10.1080/0284186x.2016.1216656

Akbaba, S., Lang, K., Held, T., Herfarth, K., Rieber, J., Plinkert, P., . . . Adeberg, S. (2019). Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety. Cancer Management and Research, 11, 1155-1166. https://doi.org/10.2147/cmar.S190051

Al-Bulushi, N. K., & Abouzied, M. E. (2016). Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors. Nuclear Medicine Communications, 37(6), 583-588. https://doi.org/10.1097/mnm.0000000000000479

Al-Mamgani, A., van Rooij, P., Mehilal, R., Tans, L., & Levendag, P. C. (2013). Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature. European Archives of Oto-Rhino-Laryngology, 270(1), 293-299. https://doi.org/10.1007/s00405-012-2008-5

Alcohol drinking. (1988). (IARC Monographs on the evaluation of carcinogenic risks to humans, Volume 44). Lyon: WHO og IARC.

Ambrosch, P. (2007). The role of laser microsurgery in the treatment of laryngeal cancer. Current Opinion in Otolaryngology & Head and Neck Surgery, 15(2), 82-88. https://doi.org/10.1097/MOO.0b013e3280147336

Amit, M., Abdelmeguid, A. S., Watcherporn, T., Takahashi, H., Tam, S., Bell, D., . . . Hanna, E. Y. (2019). Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. Journal of Clinical Oncology, 37(6), 504-512. https://doi.org/10.1200/jco.18.00353

Amols, H. I., Lagueux, B., & Cagna, D. (1986). Radiobiological effectiveness (RBE) of megavoltage X-ray and electron beams in radiotherapy. Radiation Research, 105(1), 58-67.

Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tan, P. F., . . . Gillison, M. L. (2010). Human papillomavirus and survival of patients with oropharyngeal cancer. New England Journal of Medicine, 363(1), 24-35. https://doi.org/10.1056/NEJMoa0912217

Arunachalam, P. S., Putnam, G., Jennings, P., Messersmith, R., & Robson, A. K. (2002). Role of computerized tomography (CT) scan of the chest in patients with newly diagnosed head and neck cancers. Clinical Otolaryngology and Allied Sciences, 27(5), 409-411.

Arya, S., Rane, P., & Deshmukh, A. (2014). Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management. Clinical Radiology, 69(9), 916-930. https://doi.org/10.1016/j.crad.2014.04.013

Bataini, J. P., Bernier, J., Asselain, B., Lave, C., Jaulerry, C., Brunin, F., & Pontvert, D. (1988). Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: tentative multivariate modelling system to predict the radiocurability of neck nodes. International Journal of Radiation Oncology, Biology, Physics, 14(4), 635-642.

Baujat, B., Bourhis, J., Blanchard, P., Overgaard, J., Ang, K. K., Saunders, M., . . . Pignon, J. P. (2010). Hyperfractionated or accelerated radiotherapy for head and neck cancer. The Cochrane database of systematic reviews, (12), CD002026. https://doi.org/10.1002/14651858.cd002026

Becker, M., Zbären, P., Casselman, J. W., Kohler, R., Dulguerov, P., & Becker, C. D. (2008). Neoplastic invasion of laryngeal cartilage: reassessment of criteria for diagnosis at MR imaging. Radiology, 249(2), 551-559. https://doi.org/10.1148/radiol.2492072183

Behandling af planocellulært karcinom i mundhulen: nationale retningslinjer. (2016). (3. utg.). Aarhus: DAHANCA.

Beitler, J. J., Zhang, Q., Fu, K. K., Trotti, A., Spencer, S. A., Jones, C. U., . . . Ang, K. K. (2014). Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer. International Journal of Radiation Oncology, Biology, Physics, 89(1), 13-20. https://doi.org/10.1016/j.ijrobp.2013.12.027

Belsky, J. L., Tachikawa, K., Cihak, R. W., & Yamamoto, T. (1972). Salivary gland tumors in atomic bomb survivors, Hiroshima-Nagasaki, 1957 to 1970. JAMA, 219(7), 864-868.

Bentz, B. G., Bilsky, M. H., Shah, J. P., & Kraus, D. (2003). Anterior skull base surgery for malignant tumors: a multivariate analysis of 27 years of experience. Head and Neck, 25(7), 515-520. https://doi.org/10.1002/hed.10250

Bentzen, J. D., & Hansen, H. S. (2007). Phase II analysis of paclitaxel and capecitabine in the treatment of recurrent or disseminated squamous cell carcinoma of the head and neck region. Head and Neck, 29(1), 47-51. https://doi.org/10.1002/hed.20462

Bernier, J., Cooper, J. S., Pajak, T. F., van Glabbeke, M., Bourhis, J., Forastiere, A., . . . Lefebvre, J. L. (2005). Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head and Neck, 27(10), 843-850. https://doi.org/10.1002/hed.20279

Bhattacharyya, N., & Fried, M. P. (2002). Nodal metastasis in major salivary gland cancer: predictive factors and effects on survival. Archives of Otolaryngology - Head and Neck Surgery, 128(8), 904-908.

Biau, J., Dunet, V., Lapeyre, M., Simon, C., Ozsahin, M., Gregoire, V., & Bourhis, J. (2018). Practical clinical guidelines for contouring the trigeminal nerve (V) and its branches in head and neck cancers. Radiotherapy and Oncology, Sep 8. pii: S0167-8140(18)33458-3, [Epub ahead of print]. https://doi.org/10.1016/j.radonc.2018.08.020

Biau, J., Lapeyre, M., Troussier, I., Budach, W., Giralt, J., Grau, C., . . . Gregoire, V. (2019). Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. Radiotherapy and Oncology, 134, 1-9. https://doi.org/10.1016/j.radonc.2019.01.018

Binazzi, A., Ferrante, P., & Marinaccio, A. (2015). Occupational exposure and sinonasal cancer: a systematic review and meta-analysis. BMC Cancer, 15, 49. https://doi.org/10.1186/s12885-015-1042-2

Biolchini, F., Pollastri, G., Figurelli, S., & Chiarini, L. (2005). Carcinogen metabolism, DNA damage repair and oral head and neck squamocellular carcinoma (HNSCC). A review. Minerva Stomatologica, 54(7-8), 405-414.

Biological agents: a review of human carcinogens. (2012). (IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Volume 100 B). Lyon: IRAC. Hentet fra https://monographs.iarc.fr/iarc-monographs-on-the-evaluation-of-carcinogenic-risks-to-humans-20/

Bjørndal, K., Krogdahl, A., Therkildsen, M. H., Overgaard, J., Johansen, J., Kristensen, C. A., . . . Godballe, C. (2012). Salivary gland carcinoma in Denmark 1990-2005: outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncology, 48(2), 179-185. https://doi.org/10.1016/j.oraloncology.2011.09.005

Blanchard, P., Bourhis, J., Lacas, B., Posner, M. R., Vermorken, J. B., Cruz Hernandez, J. J., . . . Pignon, J. P. (2013). Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. Journal of Clinical Oncology, 31(23), 2854-2860. https://doi.org/10.1200/jco.2012.47.7802

Blons, H., & Laurent-Puig, P. (2003). TP53 and head and neck neoplasms. Human Mutation, 21(3), 252-257. https://doi.org/10.1002/humu.10171

Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., . . . Ang, K. K. (2006). Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New England Journal of Medicine, 354(6), 567-578. https://doi.org/10.1056/NEJMoa053422

Boscolo-Rizzo, P., Schroeder, L., Romeo, S., & Pawlita, M. (2015). The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review. Clinical and Experimental Metastasis, 32(8), 835-845. https://doi.org/10.1007/s10585-015-9744-z

Bossi, P., Saba, N. F., Vermorken, J. B., Strojan, P., Pala, L., de Bree, R., . . . Ferlito, A. (2015). The role of systemic therapy in the management of sinonasal cancer: A critical review. Cancer Treatment Reviews, 41(10), 836-843. https://doi.org/10.1016/j.ctrv.2015.07.004

Bourhis, J., Overgaard, J., Audry, H., Ang, K. K., Saunders, M., Bernier, J., . . . Pignon, J. P. (2006). Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet, 368(9538), 843-854. https://doi.org/10.1016/s0140-6736(06)69121-6

Boysen, M., & Loven, J. O. (1993). Second malignant neoplasms in patients with head and neck squamous cell carcinomas. Acta Oncologica, 32(3), 283-288.

Brady, L. W., & Perez, C. A. (red.). (1998). Principles and practice of radiation oncology (3. utg.). Philadelphia: Lippincott-Ravens.

Brandstorp-Boesen, J., Falk, R. S., Boysen, M., & Brøndbo, K. (2014). Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center. European Archives of Oto-Rhino-Laryngology, 271(12), 3233-3239. https://doi.org/10.1007/s00405-014-3100-9

Brandstorp-Boesen, J., Sørum Falk, R., Boysen, M., & Brøndbo, K. (2017). Impact of stage, management and recurrence on survival rates in laryngeal cancer. PloS One, 12(7), e0179371. https://doi.org/10.1371/journal.pone.0179371

Brandstorp-Boesen, J., Sørum Falk, R., Folkvard Evensen, J., Boysen, M., & Brøndbo, K. (2016). Risk of Recurrence in Laryngeal Cancer. PloS One, 11(10), e0164068. https://doi.org/10.1371/journal.pone.0164068

Breuninger, H., & Dietz, K. (1991). Prediction of subclinical tumor infiltration in basal cell carcinoma. Journal of Dermatologic Surgery and Oncology, 17(7), 574-578.

Brouwer, C. L., Steenbakkers, R. J., Bourhis, J., Budach, W., Grau, C., Gregoire, V., . . . Langendijk, J. A. (2015). CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiotherapy and Oncology, 117(1), 83-90. https://doi.org/10.1016/j.radonc.2015.07.041

Brøndbo, K., Boysen, M., & Natvig, K. (1997). Laserkirurgi ved larynxcancer (T1a glottis). Nytt behandlingsalternativ. Tidsskr Nor Legeforen, 117(28), 4070-4071.

Brøndbo, K., Fridrich, K., & Boysen, M. (2007). Laser surgery of T1a glottic carcinomas; significance of resection margins. European Archives of Oto-Rhino-Laryngology, 264(6), 627-630. https://doi.org/10.1007/s00405-006-0233-5

Braakhuis, B. J., Tabor, M. P., Leemans, C. R., van der Waal, I., Snow, G. B., & Brakenhoff, R. H. (2002). Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head and Neck, 24(2), 198-206.

Burtness, B., Goldwasser, M. A., Flood, W., Mattar, B., Forastiere, A. A., & Eastern Cooperative Oncology Group. (2005). Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. Journal of Clinical Oncology, 23(34), 8646-8654. https://doi.org/10.1200/jco.2005.02.4646

Burtness, B., Harrington, K. J., Greil, R., Soulières, D., Tahara, M., de Castro, G., Jr., . . . Yorio, J. (2019). Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet, 394(10212), 1915-1928. https://doi.org/10.1016/S0140-6736(19)32591-7

Cacicedo, J., Navarro, A., Alongi, F., Gómez de Iturriaga, A., Del Hoyo, O., Boveda, E., . . . Bilbao, P. (2014). The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach. Cancer Treatment Reviews, 40(1), 178-189. https://doi.org/10.1016/j.ctrv.2013.08.002

Cancer in Norway 2013: cancer incidence, mortality, survival and prevalence in Norway. (2015). Oslo: Cancer Registry of Norway. Hentet fra https://www.kreftregisteret.no/globalassets/cancer-in-norway/2013/cin_2013.pdf

Cancer in Norway 2014: cancer incidence, mortality, survival and prevalence in Norway. (2015). Oslo: Cancer Registry of Norway. Hentet fra https://www.kreftregisteret.no/globalassets/cancer-in-norway/2014/cin2014-special_issue.pdf

Cancer in Norway 2016: cancer incidence, mortality, survival and prevalence in Norway. (2017). Oslo: Cancer Registry of Norway. Hentet fra https://www.kreftregisteret.no/globalassets/cancer-in-norway/2016/cin-2106-070218.pdf

Candela, F. C., Kothari, K., & Shah, J. P. (1990). Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head and Neck, 12(3), 197-203.

Chambers, K. J., Lehmann, A. E., Remenschneider, A., Dedmon, M., Meier, J., Gray, S. T., & Lin, D. T. (2015). Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States. Journal of neurological surgery. Part B, Skull base, 76(2), 94-100. https://doi.org/10.1055/s-0034-1390016

Chen, A. M., Farwell, D. G., Luu, Q., Cheng, S., Donald, P. J., & Purdy, J. A. (2011). Prospective trial of high-dose reirradiation using daily image guidance with intensity-modulated radiotherapy for recurrent and second primary head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics, 80(3), 669-676. https://doi.org/10.1016/j.ijrobp.2010.02.023

Cheraghlou, S., Torabi, S. J., Husain, Z. A., Otremba, M. D., Osborn, H. A., Mehra, S., . . . Judson, B. L. (2018). HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes. Laryngoscope. https://doi.org/10.1002/lary.27475

Cheung, R. L., Russell, A. C., & Freeman, J. (2008). Does routine preoperative imaging of parotid tumours affect surgical management decision making? Journal of Otolaryngology - Head & Neck Surgery. Le Journal d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale, 37(3), 430-434.

Chung, C. H., Parker, J. S., Karaca, G., Wu, J., Funkhouser, W. K., Moore, D., . . . Perou, C. M. (2004). Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell, 5(5), 489-500.

Cianchetti, M., Mancuso, A. A., Amdur, R. J., Werning, J. W., Kirwan, J., Morris, C. G., & Mendenhall, W. M. (2009). Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope, 119(12), 2348-2354. https://doi.org/10.1002/lary.20638

Clark, R. R., Soutar, D. S., & Hunter, K. D. (2010). A retrospective analysis of histological prognostic factors for the development of lymph node metastases from auricular squamous cell carcinoma. Histopathology, 57(1), 138-146. https://doi.org/10.1111/j.1365-2559.2010.03593.x

Cmelak, A., Li, S., Marur, S., Zhao, W., Westra, W. H., Chung, C. H., . . . Burtness, B. (2014). E1308: Reduced-dose IMRT in human papilloma virus (HPV)-associated resectable oropharyngeal squamous carcinomas (OPSCC) after clinical complete response (CCR) to induction chemotherapy (IC). Journal of Clinical Oncology, 32(18 SUPPL. 1), LBA6006.

Colevas, A. D. (2006). Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. Journal of Clinical Oncology, 24(17), 2644-2652. https://doi.org/10.1200/jco.2005.05.3348

Colevas, A. D. (2015). Systemic Therapy for Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck. Journal of the National Comprehensive Cancer Network, 13(5), e37-48. https://doi.org/10.6004/jnccn.2015.0080

Collins, B., Abernethy, J., & Barnes, L. (2010). Oral Malignant Melanoma. [nettdokument]. Newport Beach, Ca: Oral Cancer Foundation. Hentet 22. februar 2018, fra https://oralcancerfoundation.org/facts/rare/oral-malignant-melanoma/

Copper, M. P., Jovanovic, A., Nauta, J. J., Braakhuis, B. J., de Vries, N., van der Waal, I., & Snow, G. B. (1995). Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Archives of Otolaryngology - Head and Neck Surgery, 121(2), 157-160.

Corry, J., Peters, L. J., Costa, I. D., Milner, A. D., Fawns, H., Rischin, D., & Porceddu, S. (2005). The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiotherapy and Oncology, 77(2), 137-142. https://doi.org/10.1016/j.radonc.2005.10.008

Corvo, R. (2007). Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiotherapy and Oncology, 85(1), 156-170. https://doi.org/10.1016/j.radonc.2007.04.002

Cowey, C. L. (2013). Targeted therapy for advanced Basal-cell carcinoma: vismodegib and beyond. Dermatology and therapy, 3(1), 17-31. https://doi.org/10.1007/s13555-013-0019-9

DAHANCA 25 studierne – Styrketræning til hoved-halscancer patienter. (u.å.). Aarhus: DAHANCA. https://www.dahanca.dk/uploads/TilFagfolk/Guideline/GUID_Styrketraening-tilhoved-halscancer.pdf

DAHANCA Radiotherapy Guidelines. (2018). Aarhus: DAHANCA. 

Dale, E., Moan, J. M., Osnes, T. A., & Bogsrud, T. V. (2017). Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome. European Archives of Oto-Rhino-Laryngology, 274(2), 1015-1019. https://doi.org/10.1007/s00405-016-4318-5

Dammann, F., Horger, M., Mueller-Berg, M., Schlemmer, H., Claussen, C. D., Hoffman, J., . . . Bares, R. (2005). Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. AJR: American Journal of Roentgenology, 184(4), 1326-1331. https://doi.org/10.2214/ajr.184.4.01841326

Danish Head and Neck Cancer Group. (2018). [nettside]. Aarhus: DAHANCA. Hentet 14. februar 2018, fra https://www.dahanca.oncology.dk/

de Bondt, R. B., Nelemans, P. J., Hofman, P. A., Casselman, J. W., Kremer, B., van Engelshoven, J. M., & Beets-Tan, R. G. (2007). Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. European Journal of Radiology, 64(2), 266-272. https://doi.org/10.1016/j.ejrad.2007.02.037

de Bree, R., Deurloo, E. E., Snow, G. B., & Leemans, C. R. (2000). Screening for distant metastases in patients with head and neck cancer. Laryngoscope, 110(3 Pt 1), 397-401. https://doi.org/10.1097/00005537-200003000-00012

De Crevoisier, R., Bourhis, J., Domenge, C., Wibault, P., Koscielny, S., Lusinchi, A., . . . Eschwege, F. (1998). Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. Journal of Clinical Oncology, 16(11), 3556-3562. https://doi.org/10.1200/jco.1998.16.11.3556

DeConti, R. C. (2012). Chemotherapy of squamous cell carcinoma of the skin. Seminars in Oncology, 39(2), 145-149. https://doi.org/10.1053/j.seminoncol.2012.01.002

DeConti, R. C., & Schoenfeld, D. (1981). A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer. Cancer, 48(5), 1061-1072.

DeSantis, C., Naishadham, D., & Jemal, A. (2013). Cancer statistics for African Americans, 2013. CA: A Cancer Journal for Clinicians, 63(3), 151-166. https://doi.org/10.3322/caac.21173

Dulguerov, P., Allal, A. S., & Calcaterra, T. C. (2001). Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncology, 2(11), 683-690. https://doi.org/10.1016/s1470-2045(01)00558-7

Dysfagi - utredning av spise- og svelgefunksjon. (02. mars 2017). [nettside]. Bjørnemyr: Sunnaas sykehus. Hentet 16. mars 2018, fra https://www.sunnaas.no/behandlinger/dysfagi-utredning-av-spise-og-svelgefunksjon

Eloy, J. A., Vivero, R. J., Hoang, K., Civantos, F. J., Weed, D. T., Morcos, J. J., & Casiano, R. R. (2009). Comparison of transnasal endoscopic and open craniofacial resection for malignant tumors of the anterior skull base. Laryngoscope, 119(5), 834-840. https://doi.org/10.1002/lary.20186

Ethmoid sinus tumors; Maxillary sinus. I: Head and neck cancers. Version 2.2018. (2018). (NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)). Fort Washington, PA: National Coprehensive Cancer Network.

Faglige anbefalinger for nomenklatur for volumer i stråleterapi. (2019). (Teknisk dokument nummer 14). Østerås: Direktoratet for strålevern og atomsikkerhet. Hentet fra 
https://www.cancercareontario.ca/en/guidelines-advice/types-of-cancer/581

Fakhry, N., Santini, L., Lagier, A., Dessi, P., & Giovanni, A. (2014). Fine needle aspiration cytology and frozen section in the diagnosis of malignant parotid tumours. International Journal of Oral and Maxillofacial Surgery, 43(7), 802-805. https://doi.org/10.1016/j.ijom.2014.01.002

Fan, C. Y., Wang, J., & Barnes, E. L. (2000). Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. American Journal of Surgical Pathology, 24(4), 579-586.

Ferris, R. L. (2015). Immunology and Immunotherapy of Head and Neck Cancer. Journal of Clinical Oncology, 33(29), 3293-3304. https://doi.org/10.1200/jco.2015.61.1509

Ferris, R. L., Blumenschein, G., Jr., Fayette, J., Guigay, J., Colevas, A. D., Licitra, L., . . . Gillison, M. L. (2016). Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. New England Journal of Medicine, 375(19), 1856-1867. https://doi.org/10.1056/NEJMoa1602252

Forskrift om prioritering av helsetjenester, rett til nødvendig helsehjelp fra spesialisthelsetjenesten, rett til behandling i utlandet og om klagenemnd (prioriteringsforskriften). FOR-2000-12-01-1208. Sist endret: FOR-2019-01-11-16 fra 01.02.2019.  Hentet fra https://lovdata.no/dokument/SF/forskrift/2000-12-01-1208

Fossum, G. H., Lie, A. K., Jebsen, P., Sandlie, L. E., & Mork, J. (2017). Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival. European Archives of Oto-Rhino-Laryngology, 274(11), 4003-4010. https://doi.org/10.1007/s00405-017-4748-8

Foulkes, W. D., Brunet, J. S., Sieh, W., Black, M. J., Shenouda, G., & Narod, S. A. (1996). Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. BMJ, 313(7059), 716-721.

Frank, S. J., Rosenthal, D. I., Petsuksiri, J., Ang, K. K., Morrison, W. H., Weber, R. S., . . . Garden, A. S. (2010). Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. International Journal of Radiation Oncology, Biology, Physics, 78(4), 1005-1010. https://doi.org/10.1016/j.ijrobp.2009.09.006

Friborg, J. T., & Melbye, M. (2008). Cancer patterns in Inuit populations. Lancet Oncology, 9(9), 892-900. https://doi.org/10.1016/s1470-2045(08)70231-6

Frierson, H. F., Jr., Mills, S. E., Fechner, R. E., Taxy, J. B., & Levine, P. A. (1986). Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma. American Journal of Surgical Pathology, 10(11), 771-779.

Fujimoto, R., Higashi, T., Nakamoto, Y., Hara, T., Lyshchik, A., Ishizu, K., . . . Togashi, K. (2006). Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET. Annals of Nuclear Medicine, 20(6), 399-408.

Furness, S., Glenny, A. M., Worthington, H. V., Pavitt, S., Oliver, R., Clarkson, J. E., . . . Conway, D. I. (2011). Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. The Cochrane database of systematic reviews, (4), CD006386. https://doi.org/10.1002/14651858.CD006386.pub3

Galloway, T., & Amdur, R. (2016). Management of late complications of head and neck cancer and its treatment. UpToDate [Database]. Waltham, MA: UpToDate, Inc. Hentet 30. juni 2016

Ganti, A. K., & Kessinger, A. (2011). Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer. Cancer Treatment Reviews, 37(6), 440-443. https://doi.org/10.1016/j.ctrv.2010.12.002

Gilbert, J., Murphy, B. A., & Jackson, L. (2016). Health-related quality of life in head and neck cancer. UpToDate [Database]. Waltham, MA: UpToDate, Inc. Hentet 30. juni 2016

Glisson, B. S., Murphy, B. A., Frenette, G., Khuri, F. R., & Forastiere, A. A. (2002). Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck. Journal of Clinical Oncology, 20(6), 1593-1599. https://doi.org/10.1200/jco.2002.20.6.1593

Gnepp, D. R., Henley, D., Simpson, R., & Eveson, R. (2009). Salivary and lacrimal glands. I: D. R. Gnepp (red.), Diagnostic surgical pathology of the head and neck (2. utg., s. 413-562). Philadelphia: Saunders Elsevier.

Gordon, I., Boffetta, P., & Demers, P. A. (1998). A case study comparing a meta-analysis and a pooled analysis of studies of sinonasal cancer among wood workers. Epidemiology, 9(5), 518-524.

Govers, T. M., Hannink, G., Merkx, M. A., Takes, R. P., & Rovers, M. M. (2013). Sentinel node biopsy for squamous cell carcinoma of the oral cavity and oropharynx: a diagnostic meta-analysis. Oral Oncology, 49(8), 726-732. https://doi.org/10.1016/j.oraloncology.2013.04.006

Grau, C., Johansen, L. V., Jakobsen, J., Geertsen, P., Andersen, E., & Jensen, B. B. (2000). Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiotherapy and Oncology, 55(2), 121-129.

Gray, S. T., Herr, M. W., Sethi, R. K., Diercks, G., Lee, L., Curry, W., . . . Lin, D. T. (2015). Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review. Head and Neck, 37(3), 366-374. https://doi.org/10.1002/hed.23606

Gregoire, V., Ang, K., Budach, W., Grau, C., Hamoir, M., Langendijk, J. A., . . . Lengele, B. (2014). Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiotherapy and Oncology, 110(1), 172-181. https://doi.org/10.1016/j.radonc.2013.10.010

Grégoire, V., Evans, M., Le, Q. T., Bourhis, J., Budach, V., Chen, A., . . . Grau, C. (2018). Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiotherapy and Oncology, 126(1), 3-24. https://doi.org/10.1016/j.radonc.2017.10.016

Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007). Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet, 370(9581), 59-67. https://doi.org/10.1016/s0140-6736(07)61050-2

Grønhøj Larsen, C., Gyldenløve, M., Jensen, D. H., Therkildsen, M. H., Kiss, K., Norrild, B., . . . von Buchwald, C. (2014). Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review. British Journal of Cancer, 110(6), 1587-1594. https://doi.org/10.1038/bjc.2014.42

Guha, N., Warnakulasuriya, S., Vlaanderen, J., & Straif, K. (2014). Betel quid chewing and the risk of oral and oropharyngeal cancers: a meta-analysis with implications for cancer control. International Journal of Cancer, 135(6), 1433-1443. https://doi.org/10.1002/ijc.28643

Guidance on cancer services: improving outcomes in head and neck cancers: the manual. (2004). London: National Institute for Clinical Excellence. Hentet fra https://www.nice.org.uk/guidance/csg6/resources/improving-outcomes-in-head-and-neck-cancers-update-pdf-773377597

Guigay, J., Fayette, J., Mesia, R., Lafond, C., Saada-Bouzid, E., Geoffrois, L., . . . Unicancer, N. (2019). TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Journal of Clinical Oncology, 37(15_suppl), 6002. https://doi.org/10.1200/JCO.2019.37.15_suppl.6002

Halkjelsvik, T., Lund, K. E., Kraft, P., & Rise, J. (2013). Fear appeals in advanced tobacco control environments: the impact of a national mass media campaign in Norway. Health Education Research, 28(5), 888-897. https://doi.org/10.1093/her/cyt064

Halperin, E. C., Wazer, D. E., Perez, C. A., & Brady, L. W. (2013). Perez and Brady's principles and practice of radiation oncology (6. utg.). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins.

Hammarstedt, L., Lindquist, D., Dahlstrand, H., Romanitan, M., Dahlgren, L. O., Joneberg, J., . . . Munck-Wikland, E. (2006). Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. International Journal of Cancer, 119(11), 2620-2623. https://doi.org/10.1002/ijc.22177

Hannisdal, K., Boysen, M., & Evensen, J. F. (2003). Different prognostic indices in 310 patients with tonsillar carcinomas. Head and Neck, 25(2), 123-131. https://doi.org/10.1002/hed.10175

Harabuchi, Y., Yamanaka, N., Kataura, A., Imai, S., Kinoshita, T., Mizuno, F., & Osato, T. (1990). Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet, 335(8682), 128-130.

Hashibe, M., Brennan, P., Chuang, S. C., Boccia, S., Castellsague, X., Chen, C., . . . Boffetta, P. (2009). Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiology, Biomarkers and Prevention, 18(2), 541-550. https://doi.org/10.1158/1055-9965.epi-08-0347

Hassan Metwally, M. A., Ali, R., Kuddu, M., Shouman, T., Strojan, P., Iqbal, K., . . . Overgaard, J. (2015). IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma. Radiotherapy and Oncology, 116(1), 15-20. https://doi.org/10.1016/j.radonc.2015.04.005

Haughey, B. H., Gates, G. A., Arfken, C. L., & Harvey, J. (1992). Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Annals of Otology, Rhinology and Laryngology, 101(2 Pt 1), 105-112. https://doi.org/10.1177/000348949210100201

Head and neck cancers. Version 1.2015. (2015). (NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)). Fort Washington, PA: National Coprehensive Cancer Network.

Head and neck cancers. Version 2.2018. (2018). (NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)). Fort Washington, PA: National Coprehensive Cancer Network.

Helserisiko ved bruk av snus. (2014). Oslo: Folkehelseinstituttet. Hentet fra https://www.fhi.no/globalassets/dokumenterfiler/moba/pdf/helserisiko-ved-bruk-av-snus-pdf.pdf

Hitt, R., Irigoyen, A., Cortes-Funes, H., Grau, J. J., Garcia-Saenz, J. A., & Cruz-Hernandez, J. J. (2012). Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck. Annals of Oncology, 23(4), 1016-1022. https://doi.org/10.1093/annonc/mdr367

Ho, F. C., Tham, I. W., Earnest, A., Lee, K. M., & Lu, J. J. (2012). Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence. BMC Cancer, 12, 98. https://doi.org/10.1186/1471-2407-12-98

Holmes, B. J., & Wenig, B. M. (2019). Virus-associated carcinomas of the head & neck: Update from the 2017 WHO classification. Annals of Diagnostic Pathology, 38, 29-42. https://doi.org/10.1016/j.anndiagpath.2018.10.008

Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., . . . et al. (1990). Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. New England Journal of Medicine, 323(12), 795-801. https://doi.org/10.1056/nejm199009203231205

Howard, D. J., Lund, V. J., & Wei, W. I. (2006). Craniofacial resection for tumors of the nasal cavity and paranasal sinuses: a 25-year experience. Head and Neck, 28(10), 867-873. https://doi.org/10.1002/hed.20432

Huang, S. H., Waldron, J., Bratman, S. V., Su, J., Kim, J., Bayley, A., . . . O'Sullivan, B. (2017). Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later. International Journal of Radiation Oncology, Biology, Physics, 98(1), 159-169. https://doi.org/10.1016/j.ijrobp.2017.01.018

Hui, E. P., & Chan, A. T. C. (5. februar 2018). Epidemiology, etiology, and diagnosis of nasopharyngeal carcinoma. UpToDate [Database]. Waltham, MA: UpToDate, Inc. Hentet 14. februar 2018

Human papillomaviruses. (2007). (IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Volume 90). Lyon: IRAC. Hentet fra https://monographs.iarc.fr/iarc-monographs-on-the-evaluation-of-carcinogenic-risks-to-humans-31/

Iannetti, G., Valentini, V., Rinna, C., Ventucci, E., & Marianetti, T. M. (2005). Ethmoido-orbital tumors: our experience. Journal of Craniofacial Surgery, 16(6), 1085-1091.

Isles, M. G., McConkey, C., & Mehanna, H. M. (2008). A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clinical Otolaryngology, 33(3), 210-222. https://doi.org/10.1111/j.1749-4486.2008.01688.x

Kato, H., Kanematsu, M., Watanabe, H., Mizuta, K., & Aoki, M. (2014). Salivary gland tumors of the parotid gland: CT and MR imaging findings with emphasis on intratumoral cystic components. Neuroradiology, 56(9), 789-795. https://doi.org/10.1007/s00234-014-1386-3

Kaufman, H. L., Russell, J., Hamid, O., Bhatia, S., Terheyden, P., D'Angelo, S. P., . . . Nghiem, P. (2016). Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Lancet Oncology, 17(10), 1374-1385. https://doi.org/10.1016/s1470-2045(16)30364-3

Khan, L., Choo, R., Breen, D., Assaad, D., Fialkov, J., Antonyshyn, O., . . . Barnes, E. (2012). Recommendations for CTV margins in radiotherapy planning for non melanoma skin cancer. Radiotherapy and Oncology, 104(2), 263-266. https://doi.org/10.1016/j.radonc.2012.06.013

Kim, B. S., Vongtama, R., & Juillard, G. (2004). Sinonasal undifferentiated carcinoma: case series and literature review. American Journal of Otolaryngology, 25(3), 162-166.

Kim, Y. S. (2017). Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence. Radiation oncology journal, 35(1), 1-15. https://doi.org/10.3857/roj.2017.00122

King, A. D., Ahuja, A. T., Leung, S. F., Lam, W. W., Teo, P., Chan, Y. L., & Metreweli, C. (2000). Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head and Neck, 22(3), 275-281.

King, A. D., & Bhatia, K. S. (2010). Magnetic resonance imaging staging of nasopharyngeal carcinoma in the head and neck. World J Radiol, 2(5), 159-165. https://doi.org/10.4329/wjr.v2.i5.159

King, A. D., Ma, B. B., Yau, Y. Y., Zee, B., Leung, S. F., Wong, J. K., . . . Chan, A. T. (2008). The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. British Journal of Radiology, 81(964), 291-298. https://doi.org/10.1259/bjr/73751469

Kirkpatrick, J. P., van der Kogel, A. J., & Schultheiss, T. E. (2010). Radiation dose-volume effects in the spinal cord. International Journal of Radiation Oncology, Biology, Physics, 76(3 Suppl), S42-49. https://doi.org/10.1016/j.ijrobp.2009.04.095

Klass, C. M., & Shin, D. M. (2007). Current status and future perspectives of chemoprevention in head and neck cancer. Current Cancer Drug Targets, 7(7), 623-632.

Kolk, A., Wolff, K. D., Smeets, R., Kesting, M., Hein, R., & Eckert, A. W. (2014). Melanotic and non-melanotic malignancies of the face and external ear - A review of current treatment concepts and future options. Cancer Treatment Reviews, 40(7), 819-837. https://doi.org/10.1016/j.ctrv.2014.04.002

Koto, M., Demizu, Y., Saitoh, J. I., Suefuji, H., Tsuji, H., Okimoto, T., . . . Kamada, T. (2017). Multicenter Study of Carbon-Ion Radiation Therapy for Mucosal Melanoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN). International Journal of Radiation Oncology, Biology, Physics, 97(5), 1054-1060. https://doi.org/10.1016/j.ijrobp.2016.12.028

Kræft i næse og bihuler: nationale retningslinjer for udredning, behandling og rehabilitering af patienter med maligne tumorer i cavum nasi, de paranasale bihuler og vestibulum nasi. (2017). Aarhus: Dansk Selskab for Hoved- og Hals Onkologi (DSHHO) og Dansk Hoved-hals Cancer Gruppe (DAHANCA) 

Kwon, M., Roh, J. L., Lee, J., Cho, K. J., Choi, S. H., Nam, S. Y., & Kim, S. Y. (2015). Extranodal extension and thickness of metastatic lymph node as a significant prognostic marker of recurrence and survival in head and neck squamous cell carcinoma. Journal of Cranio-Maxillo-Facial Surgery, 43(6), 769-778. https://doi.org/10.1016/j.jcms.2015.04.021

Kyzas, P. A., Evangelou, E., Denaxa-Kyza, D., & Ioannidis, J. P. (2008). 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. Journal of the National Cancer Institute, 100(10), 712-720. https://doi.org/10.1093/jnci/djn125

König, M., Osnes, T., Jebsen, P., Evensen, J. F., & Meling, T. R. (2018). Olfactory neuroblastoma: a single-center experience. Neurosurgical Review, 41(1), 323-331. https://doi.org/10.1007/s10143-017-0859-3

König, M., Osnes, T., Jebsen, P., & Meling, T. R. (2018). Craniofacial resection of malignant tumors of the anterior skull base: a case series and a systematic review. Acta Neurochirurgica, 160(12), 2339-2348. https://doi.org/10.1007/s00701-018-3716-4

Kaanders, J. H., Hordijk, G. J., & Dutch Cooperative Head and Neck Oncology Group. (2002). Carcinoma of the larynx: the Dutch national guideline for diagnostics, treatment, supportive care and rehabilitation. Radiotherapy and Oncology, 63(3), 299-307.

Lacchetti, C., Waldron, J., Perez-Ordonez, B., Kamel-Reid, S., Cripps, C., & Gilbert, R. (2013). Routine Human Papilloma Virus (HPV) Testing in Squamous Cell Head and Neck Cancer (Evidence-Based Series 5-9 IN REVIEW). Toronto: Cancer Care Ontario. Hentet fra https://www.cancercareontario.ca/en/guidelines-advice/types-of-cancer/581

Lagha, A., Chraiet, N., Ayadi, M., Krimi, S., Allani, B., Rifi, H., . . . Mezlini, A. (2012). Systemic therapy in the management of metastatic or advanced salivary gland cancers. Head & Neck Oncology, 4, 19. https://doi.org/10.1186/1758-3284-4-19

Lambrecht, M., Eekers, D. B. P., Alapetite, C., Burnet, N. G., Calugaru, V., Coremans, I. E. M., . . . Troost, E. G. C. (2018). Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus. Radiotherapy and Oncology, 128(1), 26-36. https://doi.org/10.1016/j.radonc.2018.05.001

Langerman, A., Plein, C., Vokes, E. E., Salama, J. K., Haraf, D. J., Blair, E. A., & Stenson, K. M. (2009). Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer. Archives of Otolaryngology - Head and Neck Surgery, 135(11), 1133-1136. https://doi.org/10.1001/archoto.2009.154

Laurie, S. A., Ho, A. L., Fury, M. G., Sherman, E., & Pfister, D. G. (2011). Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review. Lancet Oncology, 12(8), 815-824. https://doi.org/10.1016/s1470-2045(10)70245-x

Lee, A. W., Ng, W. T., Pan, J. J., Poh, S. S., Ahn, Y. C., AlHussain, H., . . . Wee, J. T. (2018). International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiotherapy and Oncology, 126(1), 25-36. https://doi.org/10.1016/j.radonc.2017.10.032

Lee, J. R., Kim, J. S., Roh, J. L., Lee, J. H., Baek, J. H., Cho, K. J., . . . Kim, S. Y. (2015). Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study. Radiology, 274(3), 764-771. https://doi.org/10.1148/radiol.14141073

Lee, Y. Y., Wong, K. T., King, A. D., & Ahuja, A. T. (2008). Imaging of salivary gland tumours. European Journal of Radiology, 66(3), 419-436. https://doi.org/10.1016/j.ejrad.2008.01.027

Leong, S. P. (2011). Role of selective sentinel lymph node dissection in head and neck melanoma. Journal of Surgical Oncology, 104(4), 361-368. https://doi.org/10.1002/jso.21964

Leslie, A., Fyfe, E., Guest, P., Goddard, P., & Kabala, J. E. (1999). Staging of squamous cell carcinoma of the oral cavity and oropharynx: a comparison of MRI and CT in T- and N-staging. Journal of Computer Assisted Tomography, 23(1), 43-49.

Lewis, J. S., Jr., Beadle, B., Bishop, J. A., Chernock, R. D., Colasacco, C., Lacchetti, C., . . . Faquin, W. C. (2018). Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists. Archives of Pathology and Laboratory Medicine, 142(5), 559-597. https://doi.org/10.5858/arpa.2017-0286-CP

Li, H., Torabi, S. J., Yarbrough, W. G., Mehra, S., Osborn, H. A., & Judson, B. (2018). Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival. JAMA otolaryngology-- head & neck surgery, 144(6), 519-525. https://doi.org/10.1001/jamaoto.2018.0395

Liao, L. J., Lo, W. C., Hsu, W. L., Wang, C. T., & Lai, M. S. (2012). Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities. BMC Cancer, 12, 236. https://doi.org/10.1186/1471-2407-12-236

Lindberg, R. (1972). Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer, 29(6), 1446-1449.

Locati, L. D., Quattrone, P., Bossi, P., Marchianò, A. V., Cantù, G., & Licitra, L. (2003). A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland. Annals of Oncology, 14(8), 1327-1328.

Loevner, L. A., & Sonners, A. I. (2002). Imaging of neoplasms of the paranasal sinuses. Magnetic Resonance Imaging Clinics of North America, 10(3), 467-493.

Lonneux, M., Hamoir, M., Reychler, H., Maingon, P., Duvillard, C., Calais, G., . . . Gregoire, V. (2010). Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. Journal of Clinical Oncology, 28(7), 1190-1195. https://doi.org/10.1200/jco.2009.24.6298

López, F., Rodrigo, J. P., Silver, C. E., Haigentz, M., Jr., Bishop, J. A., Strojan, P., . . . Ferlito, A. (2016). Cervical lymph node metastases from remote primary tumor sites. Head and Neck, 38 Suppl 1, E2374-2385. https://doi.org/10.1002/hed.24344

Lopez, F., Suárez, V., Vivanco, B., Suarez, C., & Llorente, J. L. (2015). Current management of sinonasal undifferentiated carcinoma. Rhinology, 53(3), 212-220. https://doi.org/10.4193/Rhin14.054

Lov om kommunale helse- og omsorgstjenester m.m. (helse- og omsorgstjenesteloven). LOV-2011-06-24-30. Sist endret: LOV-2018-12-20-113 fra 01.01.2019.  Hentet fra https://lovdata.no/dokument/NL/lov/2011-06-24-30

Lov om pasient- og brukerrettigheter (pasient- og brukerrettighetsloven). LOV-1999-07-02-63. Sist endret: LOV-2018-06-15-38 fra 20.07.2018.  Hentet fra https://lovdata.no/dokument/NL/lov/1999-07-02-63

Lucke, A. (1869). Die Lehre von den Geschwülsten in anatomischer und klinischer Beziehung  I: V. Pitha & Billroth (red.), Handbuch der allgemeinen und speciellen chirurgie. Erlangen: Verlag von Ferdinand Enke.

Lund, V. J., Clarke, P. M., Swift, A. C., McGarry, G. W., Kerawala, C., & Carnell, D. (2016). Nose and paranasal sinus tumours: United Kingdom National Multidisciplinary Guidelines. Journal of Laryngology and Otology, 130(S2), S111-s118. https://doi.org/10.1017/s0022215116000530

Lydiatt, W. M., Patel, S. G., O'Sullivan, B., Brandwein, M. S., Ridge, J. A., Migliacci, J. C., . . . Shah, J. P. (2017). Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA: A Cancer Journal for Clinicians, 67(2), 122-137. https://doi.org/10.3322/caac.21389

Mahler, V., Boysen, M., & Brøndbo, K. (2010). Radiotherapy or CO(2) laser surgery as treatment of T(1a) glottic carcinoma? European Archives of Oto-Rhino-Laryngology, 267(5), 743-750. https://doi.org/10.1007/s00405-009-1135-0

Martin, J. M., & Galloway, T. J. (2015). Evaluation and management of head and neck squamous cell carcinoma of unknown primary. Surgical Oncology Clinics of North America, 24(3), 579-591. https://doi.org/10.1016/j.soc.2015.03.007

Marur, S., Lee, J. W., Cmelak, A., Zhao, W., Westra, W. H., Chung, C. H., . . . Burtness, B. (2012). ECOG 1308: A phase II trial of induction chemotherapy followed by cetuximab with low dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx (OP). Journal of Clinical Oncology, 30(15 SUPPL. 1), 5566

Maubec, E., Petrow, P., Scheer-Senyarich, I., Duvillard, P., Lacroix, L., Gelly, J., . . . Avril, M. F. (2011). Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. Journal of Clinical Oncology, 29(25), 3419-3426. https://doi.org/10.1200/jco.2010.34.1735

McLaughlin, J. K., Gridley, G., Block, G., Winn, D. M., Preston-Martin, S., Schoenberg, J. B., . . . et al. (1988). Dietary factors in oral and pharyngeal cancer. Journal of the National Cancer Institute, 80(15), 1237-1243.

Mehanna, H., Kong, A., Hartley, A., Mistry, P., Dalby, M., Fulton-Lieuw, T., . . . Gray, A. Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy. Presentert på ESMO 2018 Congress i München,  22. Oktober 2018. Hentet fra https://oncologypro.esmo.org/Meeting-Resources/ESMO-2018-Congress/Cetuximab-versus-cisplatin-in-patients-with-HPV-positive-low-risk-oropharyngeal-cancer-receiving-radical-radiotherapy

Mehanna, H., Robinson, M., Hartley, A., Kong, A., Foran, B., Fulton-Lieuw, T., . . . Dunn, J. (2019). Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet, 393(10166), 51-60. https://doi.org/10.1016/s0140-6736(18)32752-1

Mendenhall, N. P., & Li, Z. (2013). Proton therapy. I: E. C. Halperin, L. W. Brady, C. A. Perez, & D. E. Wazer (red.), Perez and Bradys principles and practice of radiation oncology (6. utg.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins.

Merino, O. R., Lindberg, R. D., & Fletcher, G. H. (1977). An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer, 40(1), 145-151.

Merkel Cell Carcinoma Stages. (9. oktober 2018). [nettdokument]. Atlanta, GA: American Cancer Society. Hentet 17. desember 2018, fra https://www.cancer.org/cancer/merkel-cell-skin-cancer/detection-diagnosis-staging/staging.html

Montebello: nytt persoektiv på livet. (2018). [nettside]. Mesnali: Montebellosenteret. Hentet 16. februar 2018, fra https://www.montebellosenteret.no/

Mork, J., Møller, B., Dahl, T., & Bray, F. (2010). Time trends in pharyngeal cancer incidence in Norway 1981-2005: a subsite analysis based on a reabstraction and recoding of registered cases. Cancer Causes and Control, 21(9), 1397-1405. https://doi.org/10.1007/s10552-010-9567-9

Mourad, W. F., Hauerstock, D., Shourbaji, R. A., Hu, K. S., Culliney, B., Li, Z., . . . Harrison, L. B. (2013). Trimodality management of sinonasal undifferentiated carcinoma and review of the literature. American Journal of Clinical Oncology, 36(6), 584-588. https://doi.org/10.1097/COC.0b013e31825eb3a5

Munn- og halskreftforeningen. (2018). [nettside]. Oslo: Munn- og halskreftforeningen. Hentet 16. februar 2018, fra http://www.munnoghalskreft.no/

Müller von der Grün, J., Tahtali, A., Ghanaati, S., Rödel, C., & Balermpas, P. (2017). Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site – current status and challenges. Radiation Oncology, 12(1), 82. https://doi.org/10.1186/s13014-017-0817-9

Maare, C., Kjeldsen, R., Jensen, K., Andersen, M., Andersen, E., & Johansen, J. (2014). PO-0666: High dose hypofractionated radiotherapy for treatment and palliation of head and neck cancer patients. Radiotherapy and Oncology, 111(Suppl 1), S8. https://doi.org/10.1016/S0167-8140(15)30784-2

Nasjonal helseplan (2007-2010). (2006). (Særtrykk av St.prp. nr. 1 (2006-2007) kapittel 6). Oslo: Helse- og omsorgsdepartementet. Hentet fra http://www.regjeringen.no/upload/HOD/Sykehus/Nasjonal_helseplan_Sartrykk.pdf

Nasjonal strategi for kreftområdet 2006-2009. (2006). Oslo: Helse- og omsorgsdepartementet. Hentet fra https://www.regjeringen.no/globalassets/upload/hod/sykehus/kreftstrategi-2006-2009.pdf

Nasjonalt handlingsprogram for palliasjon i kreftomsorgen. (2015). (IS-2285). Oslo: Helsedirektoratet. Hentet fra https://helsedirektoratet.no/retningslinjer/nasjonalt-handlingsprogram-med-retningslinjer-for-palliasjon-i-kreftomsorgen

Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av maligne melanomer. (2019). (8. utg.). (IS-2853). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/retningslinjer/maligne-melanomer-handlingsprogram

Nasjonalt handlingsprogram med retningslinjer for palliasjon i kreftomsorgen (2015). [nettdokument]. Oslo: Helsedirektoratet. Hentet 16. februar 2018, fra http://www.helsebiblioteket.no/Retningslinjer/Palliasjon/Forord

Ndiaye, C., Mena, M., Alemany, L., Arbyn, M., Castellsagué, X., Laporte, L., . . . Trottier, H. (2014). HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncology, 15(12), 1319-1331. https://doi.org/10.1016/s1470-2045(14)70471-1

Nicolaidou, E., Mikrova, A., Antoniou, C., & Katsambas, A. D. (2012). Advances in Merkel cell carcinoma pathogenesis and management: a recently discovered virus, a new international consensus staging system and new diagnostic codes. British Journal of Dermatology, 166(1), 16-21. https://doi.org/10.1111/j.1365-2133.2011.10562.x

Nishio, N., Fujimoto, Y., Fujii, M., Saito, K., Hiramatsu, M., Maruo, T., . . . Nakashima, T. (2015). Craniofacial Resection for T4 Maxillary Sinus Carcinoma: Managing Cases with Involvement of the Skull Base. Otolaryngology and Head and Neck Surgery, 153(2), 231-238. https://doi.org/10.1177/0194599815586770

NORDCAN prosjektet. (20. desember 2017 ). [nettressurs]. [s.l.]: Association of the Nordic Cancer Registries Hentet 14. februar 2018, fra http://www-dep.iarc.fr/nordcan.htm

Noronha, V., Joshi, A., Patil, V. M., Agarwal, J., Laskar, S. G., Budrukkar, A. N., . . . Gupta, T. (2017). Phase III randomized trial comparing weekly versus three-weekly (W3W) cisplatin in patients receiving chemoradiation for locally advanced head and neck cancer. Journal of Clinical Oncology, 35(15 suppl), 6007.

Nutting, C. M., Morden, J. P., Harrington, K. J., Urbano, T. G., Bhide, S. A., Clark, C., . . . Hall, E. (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncology, 12(2), 127-136. https://doi.org/10.1016/s1470-2045(10)70290-4

Nygård, M., Aagnes, B., Bray, F., Møller, B., & Mork, J. (2012). Population-based evidence of increased survival in human papillomavirus-related head and neck cancer. European Journal of Cancer, 48(9), 1341-1346. https://doi.org/10.1016/j.ejca.2012.03.014

O'Sullivan, B., Huang, S. H., Siu, L. L., Waldron, J., Zhao, H., Perez-Ordonez, B., . . . Xu, W. (2013). Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. Journal of Clinical Oncology, 31(5), 543-550. https://doi.org/10.1200/jco.2012.44.0164

O'Sullivan, B., Warde, P., Grice, B., Goh, C., Payne, D., Liu, F. F., . . . Cummings, B. (2001). The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. International Journal of Radiation Oncology, Biology, Physics, 51(2), 332-343.

Opfølgningsprogram for hoved- og halskræft. (2015). København: Sundhedsstyrelsen. Hentet fra https://www.dahanca.dk/uploads/TilFagfolk/Guideline/GUID_Opfolgningsprogram_for_hovedhalskraeft_2015.pdf

Oppfølging og etterkontroll etter avsluttet kurativ behandling I. (2017). Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av maligne melanomer (6. utg.). Oslo: Helsedirektoratet. Hentet fra https://www.helsebiblioteket.no/retningslinjer/maligne-melanomer/oppfølging_og_kontroll

Overgaard, J., Hansen, H. S., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L., . . . Jørgensen, K. (1998). A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiotherapy and Oncology, 46(2), 135-146.

Overgaard, J., Hansen, H. S., Specht, L., Overgaard, M., Grau, C., Andersen, E., . . . Evensen, J. F. (2003). Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet, 362(9388), 933-940.

Ow, T. J., & Myers, J. N. (2011). Current management of advanced resectable oral cavity squamous cell carcinoma. Clinical and Experimental Otorhinolaryngology, 4(1), 1-10. https://doi.org/10.3342/ceo.2011.4.1.1

Pantanowotz, L., & Deeken, J. F. (8. januar 2018). HIV infection and malignancy: management considerations. UpToDate [Database]. Waltham, MA: UpToDate, Inc. Hentet 14. februar 2018

Patel, S. G., Prasad, M. L., Escrig, M., Singh, B., Shaha, A. R., Kraus, D. H., . . . Shah, J. P. (2002). Primary mucosal malignant melanoma of the head and neck. Head and Neck, 24(3), 247-257.

Patel, S. G., Singh, B., Polluri, A., Bridger, P. G., Cantu, G., Cheesman, A. D., . . . Shah, J. P. (2003). Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer, 98(6), 1179-1187. https://doi.org/10.1002/cncr.11630

Patel, S. G., Singh, B., Stambuk, H. E., Carlson, D., Bridger, P. G., Cantu, G., . . . Shah, J. P. (2012). Craniofacial surgery for esthesioneuroblastoma: report of an international collaborative study. Journal of neurological surgery. Part B, Skull base, 73(3), 208-220. https://doi.org/10.1055/s-0032-1311754

Pathak, I., O'Brien, C. J., Petersen-Schaeffer, K., McNeil, E. B., McMahon, J., Quinn, M. J., . . . McCarthy, W. H. (2001). Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern? Head and Neck, 23(9), 785-790.

Pignon, J. P., Bourhis, J., Domenge, C., & Designé, L. (2000). Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet, 355(9208), 949-955.

Pignon, J. P., le Maître, A., Maillard, E., Bourhis, J., & MACH-NC Collaborative Group. (2009). Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiotherapy and Oncology, 92(1), 4-14. https://doi.org/10.1016/j.radonc.2009.04.014

Pommier, P., Combs, S. E., & Kamada, T. (2013). Carbon Ions. I: E. C. Halperin, L. W. Brady, C. A. Perez, & D. E. Wazer (red.), Perez and Bradys principles and practice of radiation oncology (6. utg.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins.

Porceddu, S. V., Rosser, B., Burmeister, B. H., Jones, M., Hickey, B., Baumann, K., . . . Holt, T. (2007). Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial". Radiotherapy and Oncology, 85(3), 456-462. https://doi.org/10.1016/j.radonc.2007.10.020

Prowse, S. J., Shaw, R., Ganeshan, D., Prowse, P. M., Hanlon, R., Lewis-Jones, H., & Wieshmann, H. (2013). The added value of 18F-fluorodeoxyglucose positron emission tomography computed tomography in patients with neck lymph node metastases from an unknown primary malignancy. Journal of Laryngology and Otology, 127(8), 780-787. https://doi.org/10.1017/s002221511300162x

Raghavan, U., Quraishi, S., & Bradley, P. J. (2003). Multiple primary tumors in patients diagnosed with hypopharyngeal cancer. Otolaryngology and Head and Neck Surgery, 128(3), 419-425. https://doi.org/10.1067/mhn.2003.98

Rautava, J., & Syrjanen, S. (2012). Biology of human papillomavirus infections in head and neck carcinogenesis. Head and Neck Pathology, 6 Suppl 1, S3-15. https://doi.org/10.1007/s12105-012-0367-2

Reiersen, D. A., Pahilan, M. E., & Devaiah, A. K. (2012). Meta-analysis of treatment outcomes for sinonasal undifferentiated carcinoma. Otolaryngology and Head and Neck Surgery, 147(1), 7-14. https://doi.org/10.1177/0194599812440932

Riaz, N., Morris, L. G., Lee, W., & Chan, T. A. (2014). Unraveling the molecular genetics of head and neck cancer through genome-wide approaches. Genes & diseases, 1(1), 75-86. https://doi.org/10.1016/j.gendis.2014.07.002

Roscher, I., Brevig, T., Mørk, G., Helsing, P., & Gjersvik, P. (2011). Mohs’ kirurgi ved basalcellekarsinom i ansiktet. Tidsskrift for den Norske lægeforening, 131(24), 2475-2479. https://doi.org/10.4045/tidsskr.11.0343

Rosenquist, K., Wennerberg, J., Schildt, E. B., Bladstrom, A., Goran Hansson, B., & Andersson, G. (2005). Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Oto-Laryngologica, 125(12), 1327-1336. https://doi.org/10.1080/00016480510012273

Rusthoven, K., Chen, C., Raben, D., & Kavanagh, B. (2008). Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis. International Journal of Radiation Oncology, Biology, Physics, 71(1), 192-198. https://doi.org/10.1016/j.ijrobp.2007.09.045

Rusthoven, K. E., Koshy, M., & Paulino, A. C. (2004). The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer, 101(11), 2641-2649. https://doi.org/10.1002/cncr.20687

Sakata, K., Maeda, A., Rikimaru, H., Ono, T., Koga, N., Takeshige, N., . . . Morioka, M. (2016). Advantage of Extended Craniofacial Resection for Advanced Malignant Tumors of the Nasal Cavity and Paranasal Sinuses: Long-Term Outcome and Surgical Management. World Neurosurgery, 89, 240-254. https://doi.org/10.1016/j.wneu.2016.02.019

Saku, T., Hayashi, Y., Takahara, O., Matsuura, H., Tokunaga, M., Tokunaga, M., . . . Land, C. E. (1997). Salivary gland tumors among atomic bomb survivors, 1950-1987. Cancer, 79(8), 1465-1475.

Sammen - mot kreft: nasjonal kreftstrategi 2013-2017. (2013). Oslo: Helse- og omsorgsdepartementet. https://www.iccp-portal.org/system/files/plans/kreftstrategien_2013.pdf

Samuels, S. E., Vainshtein, J., Spector, M. E., Ibrahim, M., McHugh, J. B., Tao, Y., . . . Eisbruch, A. (2015). Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy. Radiotherapy and Oncology, 116(1), 75-81. https://doi.org/10.1016/j.radonc.2015.06.006

Schneider, A. B., Lubin, J., Ron, E., Abrahams, C., Stovall, M., Goel, A., . . . Gierlowski, T. C. (1998). Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationships. Radiation Research, 149(6), 625-630.

Schoffski, P., Catimel, G., Planting, A. S., Droz, J. P., Verweij, J., Schrijvers, D., . . . Hanauske, A. R. (1999). Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group. Annals of Oncology, 10(1), 119-122. https://doi.org/10.1023/a:1008360323986

Sekulic, A., Migden, M. R., Oro, A. E., Dirix, L., Lewis, K. D., Hainsworth, J. D., . . . Hauschild, A. (2012). Efficacy and safety of vismodegib in advanced basal-cell carcinoma. New England Journal of Medicine, 366(23), 2171-2179. https://doi.org/10.1056/NEJMoa1113713

Seneffekter etter kreftbehandling: faglige råd. (2017). (IS-2551). Oslo: Helsedirektoratet. Hentet fra https://helsedirektoratet.no/publikasjoner/seneffekter-etter-kreft

Shahid Iqbal, M., Kelly, C., Kovarik, J., Goranov, B., Shaikh, G., Morgan, D., . . . Paleri, V. (2018). Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review. Radiotherapy and Oncology, 126(3), 558-567. https://doi.org/10.1016/j.radonc.2017.12.011

Shebl, F. M., Bhatia, K., & Engels, E. A. (2010). Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States. International Journal of Cancer, 126(10), 2503-2508. https://doi.org/10.1002/ijc.24930

Shellock R & D Services, Inc, & Shellock, F. G. (2018). MRIsafety.com: your information resource for MRI safety, bioeffects & patient management. [nettside]. [s.l.]: Shellock R & D Services, Inc. and Frank G. Shelloc. Hentet 14. desember 2018, fra http://www.mrisafety.com/

Sigal, R., Zagdanski, A. M., Schwaab, G., Bosq, J., Auperin, A., Laplanche, A., . . . Vanel, D. (1996). CT and MR imaging of squamous cell carcinoma of the tongue and floor of the mouth. Radiographics, 16(4), 787-810. https://doi.org/10.1148/radiographics.16.4.8835972

Simon, C., Caballero, C., Gregoire, V., Thurnher, D., Koivunen, P., Ceruse, P., . . . René Leemans, C. (2018). Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 "Best of" and 24954 "larynx preservation" study. European Journal of Cancer, 103, 69-77. https://doi.org/10.1016/j.ejca.2018.07.140

Singh, N., Eskander, A., Huang, S. H., Curtin, H., Bartlett, E., Vescan, A., . . . Yu, E. (2013). Imaging and resectability issues of sinonasal tumors. Expert Review of Anticancer Therapy, 13(3), 297-312. https://doi.org/10.1586/era.13.5

Skálová, A., Stenman, G., Simpson, R. H. W., Hellquist, H., Slouka, D., Svoboda, T., . . . Ferlito, A. (2018). The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas. American Journal of Surgical Pathology, 42(2), e11-e27. https://doi.org/10.1097/pas.0000000000000980

Smokeless tobacco and some tobacco-specific N-Nitrosamines. (2007). (IARC Monographs on the evaluation of carcinogenic risks to humans, Volume 89). Lyon: WHO og IARC.

Specht, L., Larsen, S. K., & Hansen, H. S. (2000). Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck. Annals of Oncology, 11(7), 845-849. https://doi.org/10.1023/a:1008355315205

Spencer, S. A., Harris, J., Wheeler, R. H., Machtay, M., Schultz, C., Spanos, W., . . . Ang, K. K. (2008). Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head and Neck, 30(3), 281-288. https://doi.org/10.1002/hed.20697

Strojan, P., Corry, J., Eisbruch, A., Vermorken, J. B., Mendenhall, W. M., Lee, A. W., . . . Ferlito, A. (2015). Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head and Neck, 37(1), 134-150. https://doi.org/10.1002/hed.23542

Strojan, P., Ferlito, A., Langendijk, J. A., Corry, J., Woolgar, J. A., Rinaldo, A., . . . Barnes, L. (2013). Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head and Neck, 35(2), 286-293. https://doi.org/10.1002/hed.21899

Strojan, P., Ferlito, A., Medina, J. E., Woolgar, J. A., Rinaldo, A., Robbins, K. T., . . . Barnes, L. (2013). Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head and Neck, 35(1), 123-132. https://doi.org/10.1002/hed.21898

Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629). (2017-2022). [pågående studie]. (NCT03284424). Hentet fra https://clinicaltrials.gov/ct2/show/NCT03284424

Szturz, P., Wouters, K., Kiyota, N., Tahara, M., Prabhash, K., Noronha, V., . . . Vermorken, J. B. (2017). Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data. Oncologist, 22(9), 1056-1066. https://doi.org/10.1634/theoncologist.2017-0015

Tajudeen, B. A., Arshi, A., Suh, J. D., St John, M., & Wang, M. B. (2014). Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis. JAMA otolaryngology-- head & neck surgery, 140(12), 1124-1129. https://doi.org/10.1001/jamaoto.2014.2541

Talmi, Y. P., Takes, R. P., Alon, E. E., Nixon, I. J., Lopez, F., de Bree, R., . . . Ferlito, A. (2018). Prognostic value of lymph node ratio in head and neck squamous cell carcinoma. Head and Neck, 40(5), 1082-1090. https://doi.org/10.1002/hed.25080

Tanzler, E. D., Amdur, R. J., Morris, C. G., Werning, J. W., & Mendenhall, W. M. (2016). Challenging the need for random directed biopsies of the nasopharynx, pyriform sinus, and contralateral tonsil in the workup of unknown primary squamous cell carcinoma of the head and neck. Head and Neck, 38(4), 578-581. https://doi.org/10.1002/hed.23931

Telfer, N. R., Colver, G. B., & Morton, C. A. (2008). Guidelines for the management of basal cell carcinoma. British Journal of Dermatology, 159(1), 35-48. https://doi.org/10.1111/j.1365-2133.2008.08666.x

Terhaard, C. H. (2007). Postoperative and primary radiotherapy for salivary gland carcinomas: indications, techniques, and results. International Journal of Radiation Oncology, Biology, Physics, 69(2 Suppl), S52-55. https://doi.org/10.1016/j.ijrobp.2007.04.079

TNM : classification of malignant tumours. (2017). (8. utg.). Oxford: Wiley-Blackwell.

TNM: classification of malignant tumours. (2010). (7. utg.). Oxford: Wiley-Blackwell.

Torjussen, W. (1979). Nickel as carcinogenic factor in nasal carcinoma [proceedings]. Acta Oto-Laryngologica. Supplementum, 360, 125.

Toustrup, K., Sørensen, B. S., Alsner, J., & Overgaard, J. (2012). Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy. Seminars in Radiation Oncology, 22(2), 119-127. https://doi.org/10.1016/j.semradonc.2011.12.006

Trotta, B. M., Pease, C. S., Rasamny, J. J., Raghavan, P., & Mukherjee, S. (2011). Oral cavity and oropharyngeal squamous cell cancer: key imaging findings for staging and treatment planning. Radiographics, 31(2), 339-354. https://doi.org/10.1148/rg.312105107

Trotti, A., Harris, J., Gillison, M., Eisbruch, A., Harari, P. M., Adelstein, D. J., . . . Galvin, J. M. (2018). NRG-RTOG 1016: Phase III trial comparing radiation/cetuximab to radiation/cisplatin in HPV-related cancer of the oropharynx. International Journal of Radiation Oncology, Biology, Physics, 102(5), 1604-1605.

Tumours of the Salivary Glands. I. (2005). L. Barnes, J. W. Eveson, P. Reichart, & D. Sidransky (red.), Pathology and genetics of head and neck tumours (s. 209-282). Lyon: IARC Press.

Valstar, M. H., van den Brekel, M. W., & Smeele, L. E. (2010). Interpretation of treatment outcome in the clinically node-negative neck in primary parotid carcinoma: a systematic review of the literature. Head and Neck, 32(10), 1402-1411. https://doi.org/10.1002/hed.21316

Vermorken, J. B., Mesia, R., Rivera, F., Remenar, E., Kawecki, A., Rottey, S., . . . Hitt, R. (2008). Platinum-based chemotherapy plus cetuximab in head and neck cancer. New England Journal of Medicine, 359(11), 1116-1127. https://doi.org/10.1056/NEJMoa0802656

Vermorken, J. B., Trigo, J., Hitt, R., Koralewski, P., Diaz-Rubio, E., Rolland, F., . . . Baselga, J. (2007). Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. Journal of Clinical Oncology, 25(16), 2171-2177. https://doi.org/10.1200/jco.2006.06.7447

von Buchwald, C., & Bradley, P. J. (2007). Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Current Opinion in Otolaryngology & Head and Neck Surgery, 15(2), 95-98. https://doi.org/10.1097/MOO.0b013e3280803d9b

Von Hoff, D. D., LoRusso, P. M., Rudin, C. M., Reddy, J. C., Yauch, R. L., Tibes, R., . . . Low, J. A. (2009). Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. New England Journal of Medicine, 361(12), 1164-1172. https://doi.org/10.1056/NEJMoa0905360

Vrionis, F. D., Kienstra, M. A., Rivera, M., & Padhya, T. A. (2004). Malignant tumors of the anterior skull base. Cancer Control, 11(3), 144-151. https://doi.org/10.1177/107327480401100302

Wang, C. C. (1994). To reirradiate or not to reirradiate? International Journal of Radiation Oncology, Biology, Physics, 29(4), 913; discussion 919.

Wang, T. S., Byrne, P. J., Jacobs, L. K., & Taube, J. M. (2011). Merkel cell carcinoma: update and review. Seminars in Cutaneous Medicine and Surgery, 30(1), 48-56. https://doi.org/10.1016/j.sder.2011.02.001

Wang, W. Y., Twu, C. W., Chen, H. H., Jiang, R. S., Wu, C. T., Liang, K. L., . . . Lin, J. C. (2013). Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels. Cancer, 119(5), 963-970. https://doi.org/10.1002/cncr.27853

Warner, G. C., & Cox, G. J. (2003). Evaluation of chest radiography versus chest computed tomography in screening for pulmonary malignancy in advanced head and neck cancer. Journal of Otolaryngology, 32(2), 107-109.

Watanabe, A., Taniguchi, M., Tsujie, H., Hosokawa, M., Fujita, M., & Sasaki, S. (2009). The value of narrow band imaging for early detection of laryngeal cancer. European Archives of Oto-Rhino-Laryngology, 266(7), 1017-1023. https://doi.org/10.1007/s00405-008-0835-1

Watkinson, J. C., & Clarke, R. W. (red.). (2018). Scott-Brown's Otorhinolaryngology and Head and Neck Surgery: Volume 3: Head and Neck Surgery, Plastic Surgery (8. utg.). Boca Raton: CRC Press.

WCRF International. (2018). Mouth, pharynx & larynx cancers: how diet, nutrition and physical activity affect mouth and throat cancer risk. I: Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. [nettdokument]. London: World Cancer Research Fund International. Hentet 19. februar 2020, fra https://www.wcrf.org/dietandcancer/mouth-pharynx-larynx-cancers

WCRF International. (2018). Nasopharyngeal cancer: how diet, nutrition and physical activity affect nasopharyngeal cancer risk. I: Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. [nettdokument]. London: World Cancer Research Fund International. Hentet 19. februar 2020, fra https://www.wcrf.org/dietandcancer/nasopharyngeal-cancer

Weissman, J. L., & Carrau, R. L. (2001). "Puffed-cheek" CT improves evaluation of the oral cavity. AJNR: American Journal of Neuroradiology, 22(4), 741-744.

WHO classification of head and neck tumors. (2017). (4. utg.). (WHO Classification of Tumours Volume 9). Lyon: International Agency for Research on Cancer.

Wong, L. Y., Lam, L. K., Fan, Y. W., Yuen, A. P., & Wei, W. I. (2006). Outcome analysis of patients with craniofacial resection: Hong Kong experience. ANZ Journal of Surgery, 76(5), 313-317. https://doi.org/10.1111/j.1445-2197.2006.03713.x

Wong, S. L., Balch, C. M., Hurley, P., Agarwala, S. S., Akhurst, T. J., Cochran, A., . . . Lyman, G. H. (2012). Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. Journal of Clinical Oncology, 30(23), 2912-2918. https://doi.org/10.1200/jco.2011.40.3519

Wreesmann, V. B., Katabi, N., Palmer, F. L., Montero, P. H., Migliacci, J. C., Gonen, M., . . . Patel, S. G. (2016). Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. Head and Neck, 38 Suppl 1, E1192-1199. https://doi.org/10.1002/hed.24190

Wu, L. M., Xu, J. R., Liu, M. J., Zhang, X. F., Hua, J., Zheng, J., & Hu, J. N. (2012). Value of magnetic resonance imaging for nodal staging in patients with head and neck squamous cell carcinoma: a meta-analysis. Academic Radiology, 19(3), 331-340. https://doi.org/10.1016/j.acra.2011.10.027

Wyss, A., Hashibe, M., Chuang, S. C., Lee, Y. C., Zhang, Z. F., Yu, G. P., . . . Olshan, A. F. (2013). Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. American Journal of Epidemiology, 178(5), 679-690. https://doi.org/10.1093/aje/kwt029

Xing, Y., Bronstein, Y., Ross, M. I., Askew, R. L., Lee, J. E., Gershenwald, J. E., . . . Cormier, J. N. (2011). Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. Journal of the National Cancer Institute, 103(2), 129-142. https://doi.org/10.1093/jnci/djq455

Xu, J., & Cao, Y. (2014). Radiation-induced carotid artery stenosis: a comprehensive review of the literature. Interv Neurol, 2(4), 183-192. https://doi.org/10.1159/000363068

Yeung, A. R., Liauw, S. L., Amdur, R. J., Mancuso, A. A., Hinerman, R. W., Morris, C. G., . . . Mendenhall, W. M. (2008). Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection? Cancer, 112(5), 1076-1082. https://doi.org/10.1002/cncr.23279

Yoo, J., Henderson, S., & Walker-Dilks, C. (2013). Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer. Clinical Oncology (Royal College of Radiologists), 25(4), e33-66. https://doi.org/10.1016/j.clon.2012.08.007

Zbären, P., Nuyens, M., Caversaccio, M., Greiner, R., & Stauffer, E. (2006). Postoperative radiation therapy for T1 and T2 primary parotid carcinoma: is it useful? Otolaryngology and Head and Neck Surgery, 135(1), 140-143. https://doi.org/10.1016/j.otohns.2006.03.007

Zhang, Y., Chen, L., Hu, G. Q., Zhang, N., Zhu, X. D., Yang, K. Y., . . . Ma, J. (2019). Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma. New England Journal of Medicine, 381(12), 1124-1135. https://doi.org/10.1056/NEJMoa1905287